µ-Conotoxin-CnIIIC acetate |
| Katalog-Nr.GC72133 |
µ-Conotoxin-CnIIIC acetate, ein 22-Rückstandskonopeptid, ist ein starker Antagonist des spannungsgesteuerten NaV1.4-Natriumkanals mit einem IC50 von 1,3 nM, der an der neuromuskulären Kreuzung wirkt.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
µ-Conotoxin-CnIIIC acetate, a 22-residue conopeptide, is a potent antagonist of the voltage-gated NaV1.4 sodium channel with an IC50 of 1.3 nM acting at the neuromuscular junction. µ-Conotoxin-CnIIIC acetate has myorelaxant and analgesic effects.
References:
[1]. Del Río-Sancho S, et al. Cutaneous iontophoresis of μ-conotoxin CnIIIC-A potent NaV1.4 antagonist with analgesic, anaesthetic and myorelaxant properties. Int J Pharm. 2017 Feb 25;518(1-2):59-65.
Review for µ-Conotoxin-CnIIIC acetate
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for µ-Conotoxin-CnIIIC acetate
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *